Moderna
MRNA
#1395
Rank
S$20.36 B
Marketcap
S$52.11
Share price
0.34%
Change (1 day)
14.84%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: S$20.36 Billion

As of February 2026 Moderna has a market cap of S$20.36 Billion. This makes Moderna the world's 1395th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026S$20.36 B30.09%
2025S$15.65 B-25.43%
2024S$20.99 B-58.08%
2023S$50.07 B-45.87%
2022S$92.50 B-33.55%
2021S$139.21 B154.55%
2020S$54.69 B516.25%
2019S$8.87 B29.38%
2018S$6.85 B

End of Day market cap according to different sources

On Feb 6th, 2026 the market cap of Moderna was reported to be:

S$20.35 Billion
by Nasdaq info icon info icon
S$20.36 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$734.72 B 3,508.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$384.22 B 1,786.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$386.99 B 1,800.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
S$0.71 B-96.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
S$3.78 B-81.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
S$1.05 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$55.09 B 170.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S$11.47 B-43.63%๐Ÿ‡บ๐Ÿ‡ธ USA